Skip to Content

Cochlear Ltd ADR CHEOY Stock Quote

| Rating as of


Last close prices updated as of May 30, 2023, 3:59 PM EST | USD
  • Last Close 80.67
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Large Growth
  • Day Range 79.42  –  80.13
  • Year Range 57.62  –  85.73
  • Market Cap 10.4489 Bil
  • Volume / Avg 5,103.0 /  3,302.8
  • Price / Sales 9.47
  • Price / Book 9.45
  • Forward Div Yield 1.21%
  • Trailing Div Yield 1.23%

Morningstar‘s Stock Analysis CHEOY

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CHEOY

Company Profile CHEOY

Business Description

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

1 University Avenue, Macquarie University
Sydney, NSW, 2109, AUS
Industry Medical Devices
Employees 4,500

Related Articles CHEOY

Competitors & Peers CHEOY

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of CHEOY’s competitive advantage.

Cochlear Ltd ADR


ResMed Inc


Sonova Holding AG


Demant A/S

−$1.18 (1.46%) −$5.46 (2.53%) −$3.10 (1.30%) −$3.80 (1.39%)
Market Cap
10.45 Bil30.85 Bil14.04 Bil60.22 Bil
Medical Devices Medical Instruments & Supplies Medical Devices Medical Devices

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Cochlear Ltd ADR Stock

Yes. CHEOY has a forward dividend yield of 1.21%. See CHEOY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CHEOY’s market cap is 10.45 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CHEOY’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CHEOY’s price/sales is 8.95.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

CHEOY’s price/forward earnings is 58.60.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

CHEOY’s price/book is 9.10.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See CHEOY’s valuation ratios compared to the Market Index.

CHEOY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CHEOY’s historical performance against its industry peers and the overall market.